Sanofi India
Logotype for Sanofi India Limited

Sanofi India (500674) investor relations material

Sanofi India Q4 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Sanofi India Limited
Q4 2025 earnings summary26 Feb, 2026

Executive summary

  • Year marked by significant transformation, including business model modernization, strategic demerger of the Consumer Healthcare business effective June 1, 2024, and ongoing stabilization into 2025 and 2026.

  • Focus on sustainable, profitable growth through R&D-driven, AI-enabled, and patient-centric operations, with strong execution in India's diabetes market.

  • Diabetes franchise maintained leadership, with Lantus holding 31% market share and Toujeo showing double-digit growth; Soliqua positioned for further acceleration.

  • Statutory auditors issued an unmodified opinion on the financial statements.

  • Board recommended a total dividend of ₹123 per share for 2025, subject to shareholder approval.

Financial highlights

  • Revenue from operations for 2025 was ₹18,374 million, down from ₹20,132 million in 2024; total income for FY 2025 was ₹18,571 million, down 9% year-over-year.

  • Net profit from continuing operations for 2025 was ₹3,267 million, up from ₹3,137 million in 2024.

  • Profit before tax and exceptional items for FY 2025 was ₹4,720 million, up 1% year-over-year.

  • Operating expenses reduced by 17% both for the quarter and full year compared to 2024.

  • Export sales declined by ₹1,481 million year-over-year due to the end of a contract with Zentiva and prior divestment of the Ankleshwar site.

Outlook and guidance

  • Partnership sales expected to remain volatile through 2026 due to inventory and stock replenishment cycles.

  • Diabetes business expected to continue double-digit growth, especially with Soliqua and Toujeo expansion.

  • No new product launches planned for 2026; focus remains on maximizing current portfolio and public sector expansion.

  • The company will assess the final impact of new Labour Codes on employee benefit obligations once official rules are notified.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Sanofi India earnings date

Logotype for Sanofi India Limited
Q1 202614 May, 2026
Sanofi India
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Sanofi India earnings date

Logotype for Sanofi India Limited
Q1 202614 May, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

Sanofi India Limited is an Indian pharmaceutical company engaged in the manufacturing and marketing of prescription medicines and consumer healthcare products. It offers treatments in therapeutic areas such as diabetes, cardiovascular diseases, central nervous system disorders, and dermatology. The company is a subsidiary of global healthcare company Sanofi. It is headquartered in Mumbai, India, and its shares are listed on the BSE.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage